Research programme: anti-TIRC7 modulators - GenPat77/MedImmuneAlternative Names: Anti-TIRC7 modulators research programme – GenPat77/MedImmune
Latest Information Update: 21 Jun 2007
At a glance
- Originator GenPat77 Pharmacogenetics
- Class Biological proteins; Small molecules
- Mechanism of Action T cell activation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Autoimmune disorders